PURCHASE ORDER
Active75F40126P00167
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$221.4K
obligated · signed 2 months ago
EO 14398 - PURCHASE ORDER FOR DEVELOPMENT OF A BLOOD-BRAIN BARRIER FORMATION AND INTEGRITY MODEL FOR THE EVALUATION OF POTENTIAL DEVELOPMENTAL NEUROTOXICITY
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
MIMETAS B.V.
Contract 75F40126P00167
UEI
XTSXJHQTL917
Parent Company
MIMETAS B.V.
Capabilities & Certifications
Headquarters Location
Current Obligation
$221,398
Base + Exercised Options
$221,398
Total Ceiling Value
$221,398
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.